Object. The authors tested the hypothesis in a porcine model that inhibition of nitric oxide synthesis during reduced cerebral perfusion pressure (CPP) affected the relative cerebral blood How (CBF) and the cerebrovascular resistance.
N rnuc oxide (NO) is a simple gas and a free radical with a high lipid solubility and an extremely short halflife, lasting only a few seconds in biological fluids. Nitric oxide is involved in many physiological functions and is important in control of blood pressure and blood flow in which it acts as a moment-to-moment vasodilator. The generation of NO accounts for the biological properties of the so-called endothelium-derived relaxing factor. 25 The norrnal regulation of blood flow requires the function of constitutive NO synthase within endothelial cells, which produces NO from the semiessential amino acid L-arginine in response to intracellular calcium shifts. Nitric oxide mediates vasodilation by activation of soluble guanylate cyclase in vascular smoothmuscle cells, thus increasing the concentration of cyclic guanylate monophosphate in the cells, which causes smooth-muscle relaxation with consequent vasodilation.> In the brain, NO can be derived from several sources. As in the peripheral vasculature, NO can be derived from the endothelial cells. Glial cells and neurons have also been shown to contain NO synthase. Cerebral arteries are richly innervated by nonadrenergic, noncholinergic vasodilator nerves that contain NO synthase." Because of the chemical instability of NO, its concentration has been difficult to measure, but its function can be studied by block-448 ing NO synthase activity with analogs of arginine. Based on studies in which NO synthase inhibition is used, NO has been considered to play important roles in the regulation of cerebral circulation. It participates in the maintenance of resting cerebrovascular tone and may play an important role in selected vasodilator responses of the cerebral circulation. Activation of parasympathetic fibers that innervate cerebral vessels produces NO-dependent increases in cerebral blood flow (CBF). 16 Neuron-derived NO may mediate local increases in CBF during increases in cerebral metabolism. Increases in CBF during hypercapnia also appear to be dependent on production ofNO. ] 6 Furthermore, evidence has been presented that suggests that NO participates in the mechanisms of cerebral ischemic damage." Despite the widespread attention that NO has captured in recent years and the large number of studies that have been published on the subject, there is considerable controversy regarding the role of this agent in cerebrovascular regulation.
The combination of high intracranial pressure and hypotension is common in many patients in neurosurgical wards, and maintenance of autoregulation is crucial for these patients. Cerebral vasomotor responses to changes in cerebral perfusion pressure (CPP) serve protective functions. Loss of vasomotor reactivity leads to a poor outcome in patients who receive neurosurgical intensive care 20 ,32 because the consequences of reduced perfusion pressure are greatly accentuated during failure of autoregulation. The role of NO in autoregulation of CBF is unclear. The property of cerebral resistance vessels to dilate when blood pressure is lowered depends on the integrity of the endothelium." Studies of the response of CBF to drug-induced hypotension or hemorrhage indicate that the autoregulatory mechanism that allows cerebral vasodilation to compensate for reduced arterial blood pressure is maintainedv-" or impaired> following inhibition of NO synthesis. There are no studies in which the effect of NO synthesis inhibition on CBF during high intracranial pressure has been investigated.
Our hypothesis was that inhibition ofNO synthesis during reduced CPP affects the relative CBF and cerebrovascular resistance. To study this, we used a pig model in which the cerebrospinal fluid (CSF) pressure could be varied and combined this with hemorrhage. Relative CBF was estimated using the laser Doppler flowmetry technique.
Materials and Methods

Animal Preparation and Operative Technique
The study was performed with the consent of the Norwegian Council of Animal Research Code for the Care and Use of Animals for Experimental Purposes.
Eighteen juvenile Norwegian-bred landrace pigs of either sex, each weighing between 15 and 30 kg, were used. All animals were housed with veterinary supervision; they were denied food overnight but were allowed free access to water. The animals were anesthetized with an intramuscular bolus injection ofketamine (15 mg/ kg) and anesthesia was maintained by continuous intravenous infusion of pentobarbital (15 mg/kg/hour), supplemented by occasional intravenous injections of 1 mg/kg pentobarbital and 1 mg/kg morphine to maintain the absence of pain reactions. After intubation, ventilation was established with 70% nitrous oxide/30% oxygen provided by a servoventilator at 20 breaths/minute and 5 to 7 L/ minute, adjusted to maintain nonnocapnia according to repeated blood gas measurements. Muscular paralysis was achieved by intravenous administration of pancuronium (0.1 mg/kg in repeated doses) after the surgical preparation had been completed. With the animal supine, an indwelling bladder catheter was inserted. Fluidfilled catheters were inserted into the aorta through the femoral arteries for monitoring the arterial pressure and controlling hemorrhage. Ringer's acetate solution was administered intravenously at a rate of 10 ml/kg/hour throughout the experiment.
After these preparations had been made, the animal was turned to the prone position and a longitudinal midline incision was made, extending from the glabella to C-7. The atlantooccipital membrane was defined and a catheter was inserted into the cerebellomedullary cistern and held in position by a rubber membrane and rapidly setting methyhnethacrylate glue.
Thre 5-mm diameter holes were made using a twist drill in the frontoparietal area of the skull, 10 mm from the midline on both sides, 10 mm in front of the coronal suture on one side, and 10 mm behind the coronal suture on both sides. Laser Doppler microprobes were positioned 3 to 5 mm into the cerebral cortex through small incisions in the dura. To achieve mechanical stability, the probes were stabilized in relation to the skull by inserting them through a cork that fit the hole and by gluing them to the bone with rapidly setting methyhnethacrylate glue. The probes were connected to master probes with screw couplings. The catheters were connected to pressure transducers and the zero reference was leveled at midchest. Recordings were transferred to a computer by an analog digital conversion system at a sample rate of 10 per second.
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Laser Doppler Flowmetry
Laser Doppler measurements of relative CBF were obtained using one-channel and two-channel laser Doppler flowmeters. The flowmeters have a 2-mW helium-neon laser light with a wavelength of 632.8 nm that is led by an optical fiber to a microprobe with a diameter of 0.5 mm. The magnitude and frequency distribution of the Doppler-shifted light is proportional to the number and velocity of blood cells moving through the illuminated area of the tissue. It is independent of the movement direction of the individual blood cells and, therefore, directional blood flow is not measured. A portion of the light is backscattered from the tissue. Photodetectors convert backscattered light into electrical signals, which are measured in millivolts. The flowmeters are used to measure backseattered light from tissue within 1 to 1.5 mm of the probe; they provide relative, not absolute, values of blood flow."-" Postmortem signals were considered to be zero blood flow and were subtracted from the flow values. The instruments were calibrated against a standardized latex solution, as recommended by the manufacturer. The analyzing band width of the flowmeters was set at 12 kH, the gain at 1, and the time constant of the output amplifier at 0.2 seconds. The movement artifact filters of the flowmeters were never used. The laser Doppler technique demands a stable probe to avoid movement artifacts. Blood around the probe tip causes an underestimation of the flow and the signal will also be disturbed if the probe has a large vessel in the measurement area." Whether the insertion of the probe itself causes a disturbed signal is difficult to tell, but histological studies obtained around hydrogen clearance electrodes have not revealed damage.v" We used relatively large animals because the possible brain damage inflicted by a 0.5-mm-diameter probe is relatively smaller in the brain of a large animal. Several reports have demonstrated preservation of vasoreactivity with similar invasive techniques. 13 ,14.23.28.39 Despite possible sources of error, intracerebral application of laser Doppler flowmetry provides good quality signals from brain tissue." We always used an initial stabilizing period lasting at least 60 minutes because hydrogen clearance electrodes have been shown to cause a lower flow reading for the first 60 minutes after insertion in the rat brain, but no influence on flow thereafter."
Experimental Protocol
Three laser Doppler flow signals, arterial pressure, and intracranial pressure were continuously recorded throughout the experiment. Nine pigs received 40 mg/kg nitro-L-arginine methyl ester (L-NAME) in 10 ml saline innnediately after surgical preparation and nine other pigs served as control animals. Recordings were made innnediately before and 30 minutes after the L-NAME treatment. Baseline recordings were obtained in all pigs after a stabilizing period lasting at least 60 minutes following the surgical preparation. A new set of recordings was obtained 5 minutes after the CSF had been increased to 80% of the mean arterial pressure. The intracranial pressure was reduced to baseline and, after a stabilizing period lasting at least 60 minutes, blood was withdrawn at a rate of approximately 4% ofblood volume per minute through the arterial catheter until an estimated 20 to 30% of the blood volume had been removed. Immediately after blood withdrawal had been completed, one set of measurements was made. Thirty minutes were then allowed for cardiovascular compensation before a new set of measurements was obtained. At the end of this period, arterial pressure had stopped increasing and appeared stable. The intracranial pressure was then increased to the previous high level and, after 5 minutes, the last set of recordings was obtained.
Measured and Calculated Variables and Data Treatment
Variables recorded during a 30-second period were averaged to obtain one measuring point. Laser Doppler signals from three channels were averaged for each measuring point to use in calculations. Blood volume was assumed to be 61 ml/kg body weight.' Mean arterial pressure and mean CSF pressure were calculated as the mean of all points on the curve throughout a 30-second period. ferences between the two groups with regard to cerebrovascular resistance were enhanced: cerebrovascular resistance was even more decreased in the control group and even more increased in the L-NAME-treated group relative to baseline (p < 0.05). The relative CBF tended to be more reduced in the L-NAME-treated group, but the difference was not statistically significant (p = 0.1) ( Table 5) .
Discussion
This study demonstrated that hemorrhagic hypotension causes an increase in cerebrovascular resistance when NO synthesis is inhibited, as opposed to the decrease in cerebrovascular resistance normally observed after blood loss. This increase occurred after cardiovascular compensation had taken place. The difference between the two groups was enhanced if intracranial pressure was high at the same time, and the high cerebrovascular resistance tended to decrease the relative CBF when NO synthesis was blocked.
Inhibition of NO synthesis caused the cerebrovascular resistance to increase markedly when the intracerebral pressure was elevated in pigs that were already hypovolemic, and the effect of previous hemorrhage was enhanced with subsequent high intracranial pressure. This finding may have clinical implications because it suggests that NO exerts a protective influence on the brain in the presence of combined hemorrhagic hypotension and high intracranial pressure. This is a common combination in patients who receive neurosurgical care. Nitric oxide probably has dual effects on CBF in these patients. Reduction in CPP caused by NO is undesirable, but low cerebrovascular resistance maintained by NO in this situation is probably advantageous. The reduction in CPP caused by NO can be counteracted by other agents commonly used to maintain blood pressure, but the reduction in cerebrovascular resistance, which is provided by NO, is a unique benefit because it is difficult to manipulate with pharmacological agents presently available. Whether NO donors have any place in the therapy of such patients has not been studied, but our findings emphasize the impor- 
Results
There were no differences observed between the two groups in any variable before L-NAME was given (data not shown). The L-NAME caused a decrease in relative CBF (p < 0.01) and increases in cerebrovascular resistance (p < 0.01), blood pressure (p < 0.05), and CPP (p < 0.001) ( Table 1 and Fig. 1) . The difference between the L-NAME-treated group and the control group at baseline (60 minutes after L-NAME injection) is shown in Table 2 . Cerebrovascular resistance (p < 0.05) blood pressure (p < 0.05), and CPP (p < 0.05) were significantly higher in the L-NAME-treated group and the relative CBF tended to be lower, but this difference was not statistically significant. During periods of high intracranial pressure both CPP and cerebrovascular resistance tended to increase more in the L-NAME-treated group, but the difference was not significant (Table 3 ). There was no significant difference between the groups immediately after blood loss; however, after 30 minutes of cardiovascular compensation, cerebrovascular resistance was decreased in the control group and increased in the L-NAME-treated group relative to baseline (p < 0.05) ( Table 4) . After combined hemorrhage and high intracranial pressure, dif-
Sources ofSupplies and Equipment
The servoventilator (model 90013) was manufactured by Siemens relative values expressed in arbitrary units rather than blood flow in milliliters per 100 g tissue per minute, all data were analyzed as changes from baseline. Cerebrovascular resistance was defined as the change in CPP divided by the change in relative CBF. The Student t-test was used to compare changes after intervention between the NO inhibition group and controls. The paired Student t-test was used to compare changes before and after injection of L-NAME. tance of maintaining an adequate intravascular volume in patients suffering from high intracranial pressure. This study was intended to clarify whether the removal of NO influenced the vasodilatory response to blood loss and high intracranial pressure. The possible involvement of NO in changes in cerebrovascular resistance in these situations was investigated in an indirect way: by studying the consequences of the blockade of the NO synthase enzyme, which forms NO from the guanidino group ofthe precursor molecule L-arginine both in the vascular endothelium and in brain tissue.
IO
, 25 The blocking agent L-NAME, which has been shown to exert a specific inhibitory action on the NO synthase enzyme both in vivo and in vitro, was used in the study."> The L-NAME is known to inhibit NO synthesis in endothelial cells and in central neuronal and glial cells." Arginine passes through the blood-brain barrier via a specific carrier. Arginine analogs such as L-NAME could penetrate into the central nervous system via the same carrier or via a neutral amino acid carrier. The analogs are more lipophilic than arginine, which facilitates their penetration.' Whatever the mechanism, it has been convincingly shown that systemic L-NAME inhibits NO synthase activity in brain tissue.v' The dose used in our study was based on experience obtained from other reports." The doses used in these studies vary from 3 to 60 mg/kg.> The response of the cerebrovascular circulation is a dose-related process." We have used a dose in the higher range aiming to block the NO synthesis in the brain completely, although the exact dose required for this purpose has not been clearly established." A dose of 20 mg/kg probably blocks endothelial NO synthesis completely in rats,34 but the degree of blockade of other sources of NO is difficult to quantify. The L-* Values are expressed as means :': standard deviations. The change in each animal was calculated separately by dividing the value obtained after blood loss with the value obtained before blood loss. See Table 1 for list of abbreviations.
t p < 0.05. NAME increased blood pressure by 27%, which is comparable to results from other studies. 16 This blood pressure increase indicates vasoconstriction of the systemic resistance vessels. The microcirculation was decreased by 17% and the cerebrovascular resistance increased by 47% 30 minutes after the dose was given. The decrease in CBF in large animals with a dose comparable to the one we have used has been reported to be similar to thiS. 16 ,17,24 The effect ofL-NAME on the relative CBF has been reported to be delayed and to reach full effect after more than 60 minutes.18,31 We could not confirm this because there were similar values for relative CBF after 30 and 60 minutes and CBF decreased quickly in most of our animals after L-NAME was administered. However, we used a higher dose ofL-NAME than those used in these studies and the animal species was also different.
Laser Doppler flowmetry provides a continuous estimate of blood flow in a small and very localized portion of the brain, so that changes in local circulation can be studied in real time. The laser Doppler flow probe sends a laser beam into the tissue. The laser light is reflected from cells in the tissue and the probe "senses" the reflected light. The flowmeter measures the Doppler shift of all the reflected light, and this value is proportional to the num- The regulation of systemic blood pressure and organ blood flow requires NO because it is a major cause of smooth-muscle relaxation with consequent vasodilation. 25 Nitric oxide is synthesized in endothelial cells and in some glial cells and neurons, and it is the transmitter in the nerves innervating cerebral arteries that are not adrenergic or cholinergic." Nitric oxide has been shown to maintain resting CBF and mediate the flow-metabolism coupling and carbon dioxide reaction. 16 Whether NO synthesis inhibition affects CBF after blood pressure changes is controversial. We found that L-NAME had no effect on the immediate response to hemorrhage. Some studies suggest a role for NO in CBF autoregulation.v> whereas other studies suggest that NO synthesis inhibition has no effect on the lower autoregulatory limit. 6 ,35,37 We found, however, that NO synthesis inhibition increased the cerebrovascular resistance later in the natural course of blood loss. The time period during which the pathophysiological occurrence of bleeding is studied might therefore be of importance. In addition, blood loss induces different cardiovascular compensations than drug-induced hypotension, which normally causes cerebral vasodilation." During hemorrhage, however, CBF is probably affected both by autoregulatory vasodilation and neurogenic vasoconstriction," which causes an upward shift in the lower limit of the autoregulation. In hemorrhagic hypotension, this upward shift is disadvantageous to the brain and probably related to the general cardiovascular regulation ofthe homeostasis in response to blood loss."
We are not aware of any previous reports in which the influence of NO synthesis inhibition on the effects of high intracranial pressure was studied. Our results showed that there was no significant difference between controls and L-NAME-treated animals in this situation. This suggests that NO has no, or at least minor, effects on cerebrovascular circulation during periods of high intracranial pressure. The autoregulatory responses to high intracranial pressure and arterial hypotension are similar;" the fact that we only studied the immediate (approximately 5 minutes in duration) reaction might be of importance for this conclusion. Our conclusion is valid provided there is no other effect of L-NAME that would relegate the potential NO synthesis blockade to an epiphenomenal category. Nitric oxide is 452 1. R. Rise and O. J. Kirkeby formed directly from L-arginine by NO synthase. Arginine participates in other metabolic functions like a-ketoglutarate metabolism and polyamine synthesis. Inhibition of NO synthase from arginine may therefore have unsuspected effects through these other mechanisms. 21 The L-NAME has been demonstrated to act in vitro as a muscarinic antagonist,' but does not affect the responses to acetylcholine in vivo.' The important effects of L-NAME on the cerebrovascular circulation can be abolished by giving a surplus of arginine, demonstrating that NO synthase inhibition is responsible for these effects. 16 
Conclusions
This study suggests that NO synthesis inhibition affects the autoregulatory response of the cerebral circulation after cardiovascular compensation to hemorrhage has taken place. Nitric oxide synthesis inhibition also enhances the undesirable effects of high intracanial pressure during hypovolemia.
